ACS:180 AND ADVIA CENTAUR B-TYPE NATRIURETIC PEPTIDE (BNP) ASSAYS— 510(k) K040425
Substantially EquivalentBayer Healthcare, LLC
FDA 510(k) clearance K040425 for ACS:180 AND ADVIA CENTAUR B-TYPE NATRIURETIC PEPTIDE (BNP) ASSAYS, Substantially Equivalent on 2004-06-14. Applicant: Bayer Healthcare, LLC. Device class: 2.
Clearance details
- Applicant
- Bayer Healthcare, LLC
- Product code
- Code NBC
- Device class
- Class 2
- Regulation
- 21 CFR 862.1117
- Advisory panel
- Clinical Chemistry
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Tarrytown, NY, US
Recent devices under product code NBC
view allMore clearances from Bayer Healthcare, LLC
view all- K171802 — ALEVE Direct Therapy (ALEVE Direct Therapy TENS Device)
- K152852 — ALEVE Direct Therapy (ALEVE Direct Therapy TENS device)
- K130265 — CONTOUR NEXT EZ BLOOD GLUCOSE METER
- K121190 — CONTOUR NEXT BLOOD GLUCOSE METER
- K110587 — CONTOUR LINK BLOOD GLUCOSE METER, CONTOUR BLOOD GLUCOSE TEST STRIPS, CONTOUR CONTROL SOLUTION (HIGH, NORMAL, LOW)
Data sourced from openFDA. This site is unofficial and independent of the FDA.